Literature DB >> 21979879

Effect of nucleophosmin1 haploinsufficiency on hematopoietic stem cells.

A Raval, B Kusler, W W Pang, I L Weissman, B S Mitchell, C Y Park.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21979879      PMCID： PMC4126903          DOI： 10.1038/leu.2011.270

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  7 in total

Review 1.  Nucleophosmin and cancer.

Authors:  Silvia Grisendi; Cristina Mecucci; Brunangelo Falini; Pier Paolo Pandolfi
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

2.  Role of nucleophosmin in embryonic development and tumorigenesis.

Authors:  Silvia Grisendi; Rosa Bernardi; Marco Rossi; Ke Cheng; Luipa Khandker; Katia Manova; Pier Paolo Pandolfi
Journal:  Nature       Date:  2005-07-06       Impact factor: 49.962

3.  Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice.

Authors:  E M Simpson; C C Linder; E E Sargent; M T Davisson; L E Mobraaten; J J Sharp
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

4.  Nucleophosmin is required for DNA integrity and p19Arf protein stability.

Authors:  Emanuela Colombo; Paola Bonetti; Eros Lazzerini Denchi; Paola Martinelli; Raffaella Zamponi; Jean-Christophe Marine; Kristian Helin; Brunangelo Falini; Pier Giuseppe Pelicci
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

Review 5.  5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics.

Authors:  K M Eisenmann; K J Dykema; S F Matheson; N F Kent; A D DeWard; R A West; R Tibes; K A Furge; A S Alberts
Journal:  Oncogene       Date:  2009-07-13       Impact factor: 9.867

6.  NPM1 deletion is associated with gross chromosomal rearrangements in leukemia.

Authors:  Roberta La Starza; Caterina Matteucci; Paolo Gorello; Lucia Brandimarte; Valentina Pierini; Barbara Crescenzi; Valeria Nofrini; Roberto Rosati; Enrico Gottardi; Giuseppe Saglio; Antonella Santucci; Laura Berchicci; Francesco Arcioni; Brunangelo Falini; Massimo Fabrizio Martelli; Constantina Sambani; Anna Aventin; Cristina Mecucci
Journal:  PLoS One       Date:  2010-09-21       Impact factor: 3.240

7.  Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse.

Authors:  Paolo Sportoletti; Silvia Grisendi; Samia M Majid; Ke Cheng; John G Clohessy; Agnes Viale; Julie Teruya-Feldstein; Pier Paolo Pandolfi
Journal:  Blood       Date:  2008-01-22       Impact factor: 22.113
  7 in total
  4 in total

1.  NPM1 ablation induces HSC aging and inflammation to develop myelodysplastic syndrome exacerbated by p53 loss.

Authors:  Claudia Morganti; Kyoko Ito; Chie Yanase; Amit Verma; Julie Teruya-Feldstein; Keisuke Ito
Journal:  EMBO Rep       Date:  2022-03-01       Impact factor: 9.071

2.  Reversibility of Defective Hematopoiesis Caused by Telomere Shortening in Telomerase Knockout Mice.

Authors:  Aparna Raval; Gregory K Behbehani; Le Xuan Truong Nguyen; Daniel Thomas; Brenda Kusler; Alina Garbuzov; John Ramunas; Colin Holbrook; Christopher Y Park; Helen Blau; Garry P Nolan; Steven E Artandi; Beverly S Mitchell
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

3.  The SMYD1 and skNAC transcription factors contribute to neurodegenerative diseases.

Authors:  R Dayne Mayfield; Li Zhu; Tyler A Smith; Gayatri R Tiwari; Haley O Tucker
Journal:  Brain Behav Immun Health       Date:  2020-09-01

4.  Smyd5 plays pivotal roles in both primitive and definitive hematopoiesis during zebrafish embryogenesis.

Authors:  Tomoaki Fujii; Shin-Ichiro Tsunesumi; Hiroshi Sagara; Miyo Munakata; Yoshihiro Hisaki; Takao Sekiya; Yoichi Furukawa; Kazuhiro Sakamoto; Sumiko Watanabe
Journal:  Sci Rep       Date:  2016-07-05       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.